Kano Therapeutics
Cambridge, MA
Kano Therapeutics enables safe, effective, and flexible correction of gene-length stretches of DNA through a new class of biomaterials.
kanotherapeutics.comCompany Details
Founded
- 2021
Employees
- Between 5 - 20 employees
Raised
- $7,100,000
Headquarters Location
- Cambridge, MA
Public
- No
Acquired
- No
CEO
Floris Engelhardt
Founders
- Mark BatheFloris EngelhardtJohn Vroom
Company Collections
These are collections Kano Therapeutics is a part of. Click on the collection name to view similar companies.